Allianz Asset Management GmbH lifted its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 1,229.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 100,898 shares of the company's stock after purchasing an additional 93,308 shares during the quarter. Allianz Asset Management GmbH owned 0.55% of Addus HomeCare worth $9,978,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in ADUS. Alliancebernstein L.P. increased its holdings in shares of Addus HomeCare by 0.5% in the fourth quarter. Alliancebernstein L.P. now owns 19,661 shares of the company's stock worth $2,465,000 after acquiring an additional 91 shares in the last quarter. Natixis increased its holdings in shares of Addus HomeCare by 111.9% in the fourth quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after acquiring an additional 132 shares in the last quarter. Heritage Family Offices LLP increased its holdings in shares of Addus HomeCare by 6.3% in the first quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock worth $239,000 after acquiring an additional 143 shares in the last quarter. Hohimer Wealth Management LLC increased its holdings in shares of Addus HomeCare by 6.3% in the first quarter. Hohimer Wealth Management LLC now owns 2,561 shares of the company's stock worth $253,000 after acquiring an additional 152 shares in the last quarter. Finally, Stifel Financial Corp increased its holdings in shares of Addus HomeCare by 1.2% in the fourth quarter. Stifel Financial Corp now owns 12,794 shares of the company's stock worth $1,604,000 after acquiring an additional 153 shares in the last quarter. 95.35% of the stock is owned by institutional investors.
Addus HomeCare Stock Performance
Shares of NASDAQ ADUS traded down $0.01 during midday trading on Wednesday, hitting $107.88. 156,809 shares of the company's stock were exchanged, compared to its average volume of 121,445. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.20. Addus HomeCare Corporation has a 12 month low of $88.96 and a 12 month high of $136.72. The company's 50 day moving average price is $112.14 and its 200 day moving average price is $109.08. The firm has a market capitalization of $1.98 billion, a PE ratio of 24.35, a price-to-earnings-growth ratio of 1.53 and a beta of 0.81.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The firm had revenue of $337.71 million during the quarter, compared to analysts' expectations of $341.66 million. During the same period in the previous year, the firm earned $1.21 EPS. The company's quarterly revenue was up 20.3% compared to the same quarter last year. As a group, analysts predict that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.
Insider Activity
In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm's stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the sale, the executive vice president owned 7,796 shares of the company's stock, valued at $896,540. This trade represents a 20.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 4.60% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently commented on the stock. JMP Securities restated a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a report on Wednesday, July 16th. Wall Street Zen upgraded shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. Finally, Macquarie restated an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a report on Tuesday, June 10th. Seven investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Addus HomeCare has a consensus rating of "Buy" and an average target price of $142.57.
Get Our Latest Research Report on ADUS
Addus HomeCare Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.